Science and Technology Committee (Commons)

EU regulation of the life sciences inquiry - publications

Inquiry status: Concluded
Report published. Awaiting Government response.

Due to the general election on 8 June 2017 the Committee has now closed this inquiry, Government responses to committee reports may be published in the next Parliament.

Oral evidence

  • 19 Apr 2016 - Impact of European regulation on UK life sciences - oral evidence | PDF version (PDF342 KB) HC 158 | Published 21 Apr 2016

    Evidence given by Emma Greenwood, Head of Policy Development, Cancer Research UK; Dr Ian Hudson, Chief Executive, Jonathan Mogford, Director of Policy, and John Wilkinson, Director of Devices, Medicines and Healthcare products Regulatory Agency; George Freeman MP, Parliamentary Under-Secretary of State, Department for Business, Innovation and Skills and the Department of Health.

    Watch this evidence session
  • 22 Mar 2016 - Impact of European regulation on UK life sciences - oral evidence | PDF version (PDF331 KB) HC 158 | Published 15 Apr 2016

    Evidence given by Stuart Pritchard, EU Affairs Manager, Wellcome Trust, Dr Keith Ison, and Professor Berne Ferry, representing the Shelford Group; Dr Jacqueline Barry, Director of Regulatory Affairs, Cell and Gene Therapy Catapult, Paul Browning, Head of Regulatory Affairs, Brightwake Ltd, Darren Budd, Commercial Director - UK and Ireland, BASF, and Steve Bates, Chief Executive Officer, BioIndustry Association (at 3.00pm); Professor Roger Lemon, representing the Academy of Medical Sciences, and Sir John Skehel, Vice-President and Biological Secretary, The Royal Society (at 3.45pm).

    Watch this evidence session

Written evidence

Correspondence

Receive RSS updates

Share this page